Financials data is unavailable for this security.
View more
Year on year Lasa Supergenerics Ltd had revenues fall -19.47% from 1.30bn to 1.04bn, though the company grew net income from a loss of 386.21m to a smaller loss of 217.31m.
| Gross margin | 26.41% |
|---|---|
| Net profit margin | -18.65% |
| Operating margin | -18.81% |
| Return on assets | -- |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in INRView more
In 2024, cash reserves at Lasa Supergenerics Ltd fell by 1.91m. However, the company earned 21.39m from its operations for a Cash Flow Margin of 2.05%. In addition the company used 3.98m on investing activities and also paid 19.32m in financing cash flows.
| Cash flow per share | -1.74 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | -- |
|---|---|
| Tangible book value per share | -- |
More ▼
Balance sheet in INRView more
| Current ratio | -- |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
Growth rates in INR
Year on year, growth in earnings per share excluding extraordinary items increased 43.74%.
| Div yield(5 year avg) | 0.21% |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | -- |
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 42.44 |
More ▼
